"[T]he Center for Medicare & Medicaid Innovation (CMMI), the research arm of [CMS], will implement three demonstration models ... [1] generic medications used to treat common chronic conditions. [2] A Medicaid project focused on the emerging field of cell and gene therapies. [3] A Medicare Part B model that would reduce payments for medications approved via the [FDA] Accelerated Approval pathway while the sponsors generate evidence from confirmatory trials."  MORE >>